Thermo Fisher Scientific

  • Categories
    • Advancing Materials
    • Advancing Mining
    • AnalyteGuru
    • Analyzing Metals
    • Ask a Scientist
    • Behind the Bench
    • Biotech at Scale
    • Clinical Conversations
    • Examining Food
    • Identifying Threats
    • Illuminating Semiconductors
    • Life in Atomic Resolution
    • Life in the Lab
    • OEMpowered
    • The Connected Lab
  • About Us
  • Contact
Accelerating ScienceBehind the Bench / Complex Diseases / Link between SARS-CoV-2 and MIS-C

Link between SARS-CoV-2 and MIS-C

Written by Behind The Bench Staff | Published: 06.15.2020

SARS-CoV-2 & MIS-CSARS-CoV-2 is rarely found in children, with only about 350 confirmed cases among 4 million total cases worldwide as of May 2020. However, a significant number of children and adolescents in Europe and North America who have been affected by SARS-CoV-2 end up with a complex autoimmune condition. The novel multisystem inflammatory syndrome in children (MIS-C) is a rare and dangerous inflammatory condition that can follow a SARS-CoV-2 infection, with overlapping symptoms for Kawasaki disease. Unlike Kawasaki disease however, which tends to primarily affect toddlers, MIS-C appears in older children with more severity, resulting with the inflammation of blood vessels throughout the body, affecting lymph nodes, heart, lungs, kidneys, brain, eyes, skin or gastrointestinal organs. The direct cause of MIS-C is unclear, however it is believed to be an immune response triggered by SARS-CoV-2 since many of the MIS-C samples are from a population that previously had the virus or were in close proximity with someone who was infected.

There is still much to be discovered about the relationship between SARS-CoV-2 and MIS-C:

  • Do children have more efficient immune systems to defend against SARS-CoV-2?
  • What characteristics of a population is more prone to MIS-C?
  • What changes in the immune system influence a sub-population’s susceptibility to MIS-C?
  • Are there specific host immune responses that are triggered by the SARS-CoV-2 virus that lead to MIS-C?

As MIS-C is likely a result from adverse immune responses, a survey of the immune repertoire could shed some light on the condition, with the hope of understanding its relationship with SARS-CoV-2. Targeted next-generation sequencing (NGS) is a versatile tool for studying infectious diseases like SARS-CoV-2, because it can be used for research of viral biology and immune response including:

  • Complete coverage of the SARS-CoV-2 genome and variants for coronavirus typing, discovery and epidemiology to trace genetic diversity and evolution of the virus
  • Molecular profiling of the immune repertoire (BCR IGH and TCR beta) for a deeper understanding of the composition and history of the immune system
  • Studying additional factors like gene expression and microbiota, which also influence immune responses to pathogen infection

It is clear that more research can enable a more complete picture of the correlation or causation of infectious agents and inflammatory syndromes like MIS-C.

Learn more about Ion Torrent targeted NGS for SARS-CoV-2 Research

Research Use Only. Not for use in diagnostic procedures

Share this article
187
SHARES
FacebookLinkedinTwitterMail

Comments

  1. Syed Irtiza Ahmad says

    July 1, 2020 at 6:20 am

    Why MIS -C CAUSE complications in children
    What are the threats a chlidren face
    Is dere relationship between virus and poulation genetics
    Wat are the treatment goals

  2. Colin Gale says

    September 21, 2020 at 1:25 pm

    will this lead to more research on chronic bacterial infections which seem to get ignored . poorly treated because of the paranoia over antibiotic resistence ?

The Impact of Genetic Diversity on the Future of Health and Medicine
Reading the Fliers: The Importance of SARS-CoV-2 Surveillance Research in Bats

Privacy StatementTerms & ConditionsLocationsSitemap

© 2025 Thermo Fisher Scientific. All Rights Reserved.

Talk to us

Notifications

Get news and research reviews on the topic of your choice, right in your inbox.

Subscribe Now

  • This field is for validation purposes and should be left unchanged.

×
  • Tweet
  • Facebook
  • Tweet
  • Facebook